BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 30818145)

  • 1. Cognitive deficits in subjects at risk for psychosis, first-episode and chronic schizophrenia patients.
    Liu Y; Wang G; Jin H; Lyu H; Liu Y; Guo W; Shi C; Meyers J; Wang J; Zhao J; Wu R; Smith RC; Davis JM
    Psychiatry Res; 2019 Apr; 274():235-242. PubMed ID: 30818145
    [No Abstract]   [Full Text] [Related]  

  • 2. Validity and utility of a set of clinical criteria for cognitive impairment associated with psychosis (CIAPs).
    Cuesta MJ; Sánchez-Torres AM; Lorente-Omeñaca R; Zandio M; Moreno-Izco L; Peralta V
    Psychiatry Res; 2020 Nov; 293():113404. PubMed ID: 32911349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MCCB cognitive profile in Spanish first episode schizophrenia patients.
    Rodriguez-Jimenez R; Santos JL; Dompablo M; Santabárbara J; Aparicio AI; Olmos R; Jiménez-López E; Sánchez-Morla E; Lobo A; Palomo T; Kern RS; Green MF; Nuechterlein KH; García-Fernández L
    Schizophr Res; 2019 Sep; 211():88-92. PubMed ID: 31345706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive impairments in first-episode drug-naive and chronic medicated schizophrenia: MATRICS consensus cognitive battery in a Chinese Han population.
    Wu JQ; Chen DC; Tan YL; Xiu MH; De Yang F; Soares JC; Zhang XY
    Psychiatry Res; 2016 Apr; 238():196-202. PubMed ID: 27086233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of cognitive functions in animal models of schizophrenia.
    Nikiforuk A
    Pharmacol Rep; 2018 Aug; 70(4):639-649. PubMed ID: 29894866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive functioning in first-episode schizophrenia: MATRICS Consensus Cognitive Battery (MCCB) Profile of Impairment.
    McCleery A; Ventura J; Kern RS; Subotnik KL; Gretchen-Doorly D; Green MF; Hellemann GS; Nuechterlein KH
    Schizophr Res; 2014 Aug; 157(1-3):33-9. PubMed ID: 24888526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain-derived neurotrophic factor is associated with cognitive impairments in first-episode and chronic schizophrenia.
    Yang Y; Liu Y; Wang G; Hei G; Wang X; Li R; Li L; Wu R; Zhao J
    Psychiatry Res; 2019 Mar; 273():528-536. PubMed ID: 30710808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial aggregation of MATRICS Consensus Cognitive Battery scores in a large sample of outpatients with schizophrenia and their unaffected relatives.
    Mucci A; Galderisi S; Green MF; Nuechterlein K; Rucci P; Gibertoni D; Rossi A; Rocca P; Bertolino A; Bucci P; Hellemann G; Spisto M; Palumbo D; Aguglia E; Amodeo G; Amore M; Bellomo A; Brugnoli R; Carpiniello B; Dell'Osso L; Di Fabio F; di Giannantonio M; Di Lorenzo G; Marchesi C; Monteleone P; Montemagni C; Oldani L; Romano R; Roncone R; Stratta P; Tenconi E; Vita A; Zeppegno P; Maj M;
    Psychol Med; 2018 Jun; 48(8):1359-1366. PubMed ID: 29017620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive impairments in patients with first episode psychosis: The relationship between neurophysiological and neuropsychological assessments.
    Morales-Muñoz I; Jurado-Barba R; Fernández-Guinea S; Álvarez-Alonso MJ; Rodríguez-Jiménez R; Jiménez-Arriero MA; Rubio G
    J Clin Neurosci; 2017 Feb; 36():80-87. PubMed ID: 27825609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Cognitive Assessment Interview: A comparative study in first episode and chronic patients with psychosis.
    Sánchez-Torres AM; Elosúa MR; Lorente-Omeñaca R; Moreno-Izco L; Peralta V; Cuesta MJ
    Schizophr Res; 2016 Dec; 178(1-3):80-85. PubMed ID: 27617413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive dysfunction correlates with elevated serum S100B concentration in drug-free acutely relapsed patients with schizophrenia.
    Chen S; Tian L; Chen N; Xiu M; Wang Z; Yang G; Wang C; Yang F; Tan Y
    Psychiatry Res; 2017 Jan; 247():6-11. PubMed ID: 27863321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examination of the validity of the Brief Neurocognitive Assessment (BNA) for schizophrenia.
    Fervaha G; Hill C; Agid O; Takeuchi H; Foussias G; Siddiqui I; Kern RS; Remington G
    Schizophr Res; 2015 Aug; 166(1-3):304-9. PubMed ID: 26004693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [MATRICS consensus cognitive battery--standard for the assessment of cognitive functions in clinical trials in schizophrenia].
    Jedrasik-Styła M; Ciołkiewicz A; Denisiuk M; Linke M; Parnowska D; Gruszka A; Jarema M; Wichniak A
    Psychiatr Pol; 2012; 46(2):261-71. PubMed ID: 23214396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated serum anti-NMDA receptor antibody levels in first-episode patients with schizophrenia.
    Tong J; Huang J; Luo X; Chen S; Cui Y; An H; Xiu M; Tan S; Wang Z; Yuan Y; Zhang J; Yang F; Li CR; Hong LE; Tan Y
    Brain Behav Immun; 2019 Oct; 81():213-219. PubMed ID: 31201848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The MATRICS Consensus Cognitive Battery (MCCB): performance and functional correlates.
    Lystad JU; Falkum E; Mohn C; Haaland VØ; Bull H; Evensen S; Rund BR; Ueland T
    Psychiatry Res; 2014 Dec; 220(3):1094-101. PubMed ID: 25242432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between level of cognitive impairments and functional outcome trajectories in first-episode schizophrenia.
    Fu S; Czajkowski N; Rund BR; Torgalsbøen AK
    Schizophr Res; 2017 Dec; 190():144-149. PubMed ID: 28302394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity.
    Nuechterlein KH; Green MF; Kern RS; Baade LE; Barch DM; Cohen JD; Essock S; Fenton WS; Frese FJ; Gold JM; Goldberg T; Heaton RK; Keefe RS; Kraemer H; Mesholam-Gately R; Seidman LJ; Stover E; Weinberger DR; Young AS; Zalcman S; Marder SR
    Am J Psychiatry; 2008 Feb; 165(2):203-13. PubMed ID: 18172019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of duration of untreated psychosis and premorbid intelligence on cognitive functioning in patients with first-episode schizophrenia.
    Wang MY; Ho NF; Sum MY; Collinson SL; Sim K
    Schizophr Res; 2016 Aug; 175(1-3):97-102. PubMed ID: 27146474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Brazilian standardization of the MATRICS consensus cognitive battery (MCCB): Psychometric study.
    Fonseca AO; Berberian AA; de Meneses-Gaya C; Gadelha A; Vicente MO; Nuechterlein KH; Bressan RA; Lacerda ALT
    Schizophr Res; 2017 Jul; 185():148-153. PubMed ID: 28110814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.